Taishi Yonezawa to Humans
This is a "connection" page, showing publications Taishi Yonezawa has written about Humans.
Connection Strength
0.088
-
The E3 ligase DTX2 inhibits RUNX1 function by binding its C terminus and prevents the growth of RUNX1-dependent leukemia cells. FEBS J. 2023 11; 290(21):5141-5157.
Score: 0.024
-
The ubiquitin ligase RNF38 promotes RUNX1 ubiquitination and enhances RUNX1-mediated suppression of erythroid transcription program. Biochem Biophys Res Commun. 2018 11 02; 505(3):905-909.
Score: 0.017
-
The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1. J Biol Chem. 2017 07 28; 292(30):12528-12541.
Score: 0.016
-
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity. Nat Cardiovasc Res. 2024 Dec; 3(12):1568-1583.
Score: 0.007
-
IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia. EMBO Mol Med. 2023 01 11; 15(1):e15631.
Score: 0.006
-
A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells. Cell Rep. 2021 08 24; 36(8):109576.
Score: 0.005
-
HHEX promotes myeloid transformation in cooperation with mutant ASXL1. Blood. 2020 10 01; 136(14):1670-1684.
Score: 0.005
-
Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms. Sci Rep. 2019 06 03; 9(1):8171.
Score: 0.004
-
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis. Nat Commun. 2018 07 16; 9(1):2733.
Score: 0.004